Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity

  • Read more about 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity
US Patent 6,664,263
Filed on 2003-03-03

Novel Chimeric Rev, TAT and NEF Antigens

  • Read more about Novel Chimeric Rev, TAT and NEF Antigens
Patent Cooperation Treaty
PCT/US2002/036805
Filed on 2002-11-15

Semaphorin 3 B(SEMA3B) as Diagnostic And Therapeutic Agent For Human Cancer

  • Read more about Semaphorin 3 B(SEMA3B) as Diagnostic And Therapeutic Agent For Human Cancer
US Patent 7,781,413
Filed on 2002-10-31

Use Of Discoidan Domain Receptor 1 (DDR1) And Agents That Affect The DDR1/Collagen Pathway

  • Read more about Use Of Discoidan Domain Receptor 1 (DDR1) And Agents That Affect The DDR1/Collagen Pathway
Patent Cooperation Treaty
PCT/US02/39793
Filed on 2002-12-11

DNA-BINDING POLYAMIDE DRUG CONJUGATES

  • Read more about DNA-BINDING POLYAMIDE DRUG CONJUGATES
Patent Cooperation Treaty
PCT/US03/06006
Filed on 2003-02-27

NUCLEIC ACID AND AMINO ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER AND METHODS OF SCREENING FOR AGENTS THAT MODIFY ATP-BINDING CASSETTE TRANSPORTER

  • Read more about NUCLEIC ACID AND AMINO ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER AND METHODS OF SCREENING FOR AGENTS THAT MODIFY ATP-BINDING CASSETTE TRANSPORTER
US Patent 7,141,420
Filed on 2003-01-10

Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof

  • Read more about Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof
Ukraine
2002086976M
Filed on 2001-02-23

Identification of Potential Ovarian Cancer Tumor Markers and Therapeutic Targets (

  • Read more about Identification of Potential Ovarian Cancer Tumor Markers and Therapeutic Targets (
Patent Cooperation Treaty
PCT/US03/04688
Filed on 2003-02-13

SOCS-1 Gene Methylation in Cancer

  • Read more about SOCS-1 Gene Methylation in Cancer
Patent Cooperation Treaty
PCT/US02/011790
Filed on 2002-04-15

METHOD OF PREVENTING TUMOR METASTASIS (AS FILED)

  • Read more about METHOD OF PREVENTING TUMOR METASTASIS (AS FILED)
US Application 10/270,564
Filed on 2002-10-16

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1131
  • Page 1132
  • Page 1133
  • Page 1134
  • Page 1135
  • Page 1136
  • Page 1137
  • Page 1138
  • Page 1139
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health